NASDAQ
Matinas BioPharma Holdings, Inc. (MTNB) has a fcf yield of -218.56% as of Friday, May 29, 2026. This represents a 25.09% decrease compared to its 12-month average of -174.72%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.